Altria, BLU express support for FDA e cigarette regulation
smoke, so much so to categorize e cigarette vapor as insignificant in terms of health risk. Dr. Burstyn reviewed over nine thousand observations of e liquid and e cigarette vapor chemistry and found no conclusive evidence of harm. He did however, express the desire to perform a longitudinal study to determine long term effects of e cigarette vapor, if any. Exposure to vapor from e cigarettes showed to pose no danger as well. Although previous studies have been performed on electronic cigarettes, many of them have been dismissed by the Food and Drug Administration, or misinterpreted by individuals or organizations opposed to e cigarettes. Burstyn’s study offers a procedure and format which may satisfy even the most hardened opposition to tobacco harm reduction.
In a recent article from CNBC tobacco company Altria expressed support for the regulations expected to be placed on e cigarettes. David Sylvia, a spokesman for Altria, said any FDA rules should encourage “good product guidelines and good manufacturing practices” in the category. “It should lead to better product performance and reduced variability,” Craig Weiss, CEO of BLU e cigarettes, also recently expressed his support of e cigarette regulation. E cigarette companies such as Altria, and others such as Logic,BLU and others have been either holding back from beginning campaigns to advertise their products, or preparing their products in the visage of a future regulation. This would suggest that the larger electronic cigarette companies would have a certain insight to what may lie in store for the future of electronic cigarettes.
CASAA, Igor Burstyn release new e cigarette study
The Consumer Advocates for Smokefree Alternatives Association in conjunction with Igor Burstyn of Drexel University School of Public Health have released a new study of electronic cigarettes. The determination of the study was that vapor produced from e cigarettes are far below the threshold of harm created by tobacco